HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Magda Celdran Selected Research

beta Subunit Luteinizing Hormone

2/2012Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors.
1/2011Novel retinoblastoma treatment avoids chemotherapy: the effect of optimally timed combination therapy with angiogenic and glycolytic inhibitors on LH(BETA)T(AG) retinoblastoma tumors.
12/2010Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma.
5/2010Impact of tumor-associated macrophages in LH(BETA)T(AG) mice on retinal tumor progression: relation to macrophage subtype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Magda Celdran Research Topics

Disease

4Neoplasms (Cancer)
02/2012 - 05/2010
4Retinoblastoma (Glioblastoma, Retinal)
02/2012 - 05/2010
3Retinal Neoplasms
02/2012 - 05/2010
2Hypoxia (Hypoxemia)
02/2012 - 12/2010

Drug/Important Bio-Agent (IBA)

4beta Subunit Luteinizing HormoneIBA
02/2012 - 05/2010
2Deoxyglucose (2 Deoxy D glucose)IBA
01/2011 - 12/2010
1Eosine Yellowish-(YS) (Eosin)IBA
02/2012
1Hematoxylin (Haematoxylon)IBA
02/2012
1anecortave acetateIBA
01/2011
1pimonidazoleIBA
12/2010
1Carboplatin (JM8)FDA LinkGeneric
12/2010
1Green Fluorescent ProteinsIBA
05/2010

Therapy/Procedure

3Drug Therapy (Chemotherapy)
02/2012 - 12/2010
2Therapeutics
01/2011 - 12/2010
2Injections
01/2011 - 05/2010
1Complementary Therapies (Alternative Medicine)
01/2011
1Aftercare (After-Treatment)
12/2010